VA phoenix pluvicto
Ended Awarded Last action
- Contract number
- 36C26225F0145
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $664,583
Award facts
- Contract value 100% obligated
- $664,582.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$328,690 | |
| Original award | $993,273 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, was awarded a $664,582.80 firm fixed-price delivery order by Veterans Integrated Service Network 22 (VISN 22) for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The award, issued on January 1, 2025, with an ultimate completion date of December 31, 2025, represents a call against an existing blanket purchase agreement framework. No small business set-aside was utilized for this procurement. The company supplies specialized radiopharmaceutical products to the Department of Veterans Affairs for targeted radioligand therapy in cancer treatment, with PLUVICTO specifically indicated for prostate cancer treatment through nuclear medicine interventions.
This delivery order is part of Advanced Accelerator Applications USA Inc.'s extensive federal contract portfolio with the VA, which spans multiple Veterans Integrated Service Networks and includes substantial blanket purchase agreements—notably a $49.1 million single-award BPA with VISN 9 for PLUVICTO extending through December 19, 2029. The company operates as a prime contractor with no identified subcontractors, performing all supply operations directly from its facilities in New Jersey. The firm fixed-price contract mechanism and delivery order structure enable VISN 22 to procure radiopharmaceutical products on an as-needed basis to support its nuclear medicine diagnostic and therapeutic capabilities across VA medical centers within the network.
Quick answers
Who was awarded contract 36C26225F0145?
36C26225F0145 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 1, 2025.
How much is contract 36C26225F0145 worth?
The government has obligated $664,583 on 36C26225F0145.
Is contract 36C26225F0145 an order under another contract?
Yes. 36C26225F0145 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26225F0145 competed?
The extent of competition for 36C26225F0145 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award